You are here

fulranumab

Pfizer Steps Out Of Johnson & Johnson's Shadow To Get A Tan

Seeking Alpha

Mon, 04/11/16 - 05:20 pm

That blockbuster anti-NGF pain drug fulranumab? J&J doesn't want it anymore

Fierce Biotech

Fri, 04/1/16 - 10:10 am

U.S. Regulators Probes Resuming Painkiller Trials Tied to Joint Failure

Bloomberg

Thu, 03/8/12 - 09:55 am

REGN475/SAR164877